Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Horse buyer Ellis blames IRD for bleeding bloodstock sales

David Ellis, Karaka’s biggest buyer, blames IRD for bleeding bloodstock sales

By Suze Metherell

Feb. 5 (BusinessDesk) – David Ellis, the biggest spender at New Zealand’s premiere Karaka horse sales this year, says the tax department is stifling new investment in the bloodstock industry with its interpretation of depreciation rules.

The value of yearling sales at Karaka in South Auckland have fallen in each of the past six years, reaching $69.7 million last month, down from $111.2 million in 2008. That’s below the average $83.9 million in the past seven sales. The number of catalogued horses has fallen 12 percent in that time and actual lots bought are down 18 percent.

Ellis, principle of Waikato-based Te Akau Racing stables, spent $6.8 million on 43 horses at Karaka last month, almost $3 million more than the second-largest buyer.

He was behind an investor syndicate that last year lost a High Court case against the Inland Revenue Department over depreciation on a colt that disappointed as a potential breeder and ended up being gelded. Ellis told BusinessDesk that IRD needs to take some of the blame for the decline in sales because of a lack of clarity over tax on horses bought for breeding

“It is so uncertain on what you can and can’t do, and this is a big statement from Karaka’s biggest buyer,” Ellis said.

“We are desperate as an industry for government to clarify tax issues, for example Michael Cullen increased depreciation on blood stock to encourage investment,” he said. “But the legislation is so unclear no one knows what to do.”

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Investment syndicates, such as in the Ellis case, typically purchase a horse with the intention of breeding but to establish pedigree and reputation they first put it on the racing circuit. Last year’s High Court ruling held that because the syndicate had no previous breeding record IRD could disallow any deductions until foals had been sired.

“Whether that’s fair or not, no one is able to write off the costs unless they have a pre-existing breeding business,” Andrew Babbage, a tax partner at Deloitte, told BusinessDesk. Those deductions weren’t available to one-off syndicates, which would potentially bring in new investors.

“If you’re an existing breeder and you purchase a horse the purchase is preparatory to a breeding business, and the continuing of the established breeding,” Babbage said.

This year’s top price paid was $800,000 for a Cambridge Stud colt with blood lines from Fastnet Rock and Katie Lee, less than half the top price last year of $1.97 million for a Curraghmore Stud colt from Fastnet Rock and Celebria. The record price paid at Karaka was $3.6 million in 2000 for Don Eduardo, sired by Zabeel via Diamond Lover.

The clearance rate this year rose to 78 percent and the median price paid was $45,000.

Ellis, whose Te Akau Racing also has stables in Singapore, said the global economic downturn had also contributed to the tightening in sales, as had a high kiwi dollar against the Australian dollar.

“Naturally the Australians did not spend with the same freedom as in the past, but even given that, sales were still successful – with some alarm bells centred on fresh investment in the industry,” he said.

“New Zealand industry still had good results, for example at VRC Oaks (at Melbourne’s Flemington Racecourse) Kirramosa won that race,” he said. “We’ve won international races in Hong Kong, Singapore, Australia. The industry still performs well but could perform a lot better if we clarified the tax issues.”

(BusinessDesk)

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.